A FAST score is a non-invasive test result used to identify people with a serious form of fatty liver disease. It combines three measurements into a single number between 0 and 1, helping doctors determine whether your liver has both active inflammation and significant scarring without needing a biopsy. The name stands for FibroScan-AST, referring to the two tools used to generate it.
What the FAST Score Measures
The FAST score pulls together three pieces of data. Two come from a FibroScan exam (a specialized ultrasound device placed against your side), and one comes from a blood test:
- Liver stiffness: Measured by the FibroScan, this reflects how much scarring (fibrosis) is present. Stiffer liver tissue means more damage.
- Fat content: Also measured by the FibroScan using a feature called the controlled attenuation parameter. This tells your doctor how much fat has built up in the liver.
- AST level: A liver enzyme measured through a standard blood draw. Elevated AST signals that liver cells are actively being damaged.
These three values are fed into a formula that produces a single number. That number tells your doctor whether your fatty liver disease has progressed to a stage that needs closer attention or treatment.
What the Score Is Looking For
The FAST score was designed to detect a specific condition sometimes called “at-risk MASH” (metabolic dysfunction-associated steatohepatitis). This means your liver has both active inflammatory damage and at least moderate scarring. In clinical terms, it identifies people with a disease activity score of 4 or higher and fibrosis at stage 2 or above on a 0-to-4 scale.
This matters because not everyone with a fatty liver is in danger. Many people carry extra fat in their liver for years without it causing serious harm. The FAST score helps separate those who are at genuine risk of progressing to cirrhosis from those who can be monitored more conservatively. It’s also used to identify candidates for newer liver-targeted medications, since these drugs are generally reserved for people whose disease has reached this threshold.
How to Read Your FAST Score
Your result falls somewhere between 0 and 1, and doctors use two cutoff values to sort patients into three groups:
- Below 0.35 (rule-out zone): At-risk liver disease is unlikely. In validation studies, this cutoff correctly identified people without significant disease 73 to 100 percent of the time. If your score is here, your doctor will likely recommend lifestyle monitoring rather than aggressive treatment.
- Between 0.35 and 0.67 (gray zone): The result is uncertain. You may need additional testing, such as repeat imaging or potentially a liver biopsy, to get a clearer picture.
- Above 0.67 (rule-in zone): Active, scarring fatty liver disease is likely. In the original study published in The Lancet Gastroenterology & Hepatology, this cutoff had a positive predictive value of 83 percent, meaning roughly 4 out of 5 people scoring above 0.67 truly had at-risk disease when confirmed by biopsy.
The dual-cutoff approach is intentional. Rather than forcing a single yes-or-no answer, it creates a confident “no” zone, a confident “yes” zone, and an honest middle ground where more information is needed.
How Accurate It Is
When the FAST score was validated across multiple international patient groups totaling over 1,000 people, it performed consistently well, with overall accuracy ranging from 0.74 to 0.95 on the standard scale used to evaluate diagnostic tests (where 1.0 would be perfect). The pooled accuracy across all validation groups was 0.85, which is considered good for a non-invasive screening tool.
No screening test is perfect, and the FAST score does have limitations. Its accuracy can vary depending on the population being tested. In some validation groups, the positive predictive value at the 0.67 cutoff was as low as 33 percent, meaning false positives are possible, particularly in populations where severe fatty liver disease is less common. That’s why a high FAST score often leads to further evaluation rather than immediate treatment decisions on its own.
What to Expect During the Test
Getting a FAST score requires two things: a FibroScan exam and a blood draw for your AST level. The blood draw is routine. The FibroScan itself is painless and takes about 10 to 15 minutes.
During the exam, you lie on your back with your right arm raised above your head. A technician places a small probe against your right side, near your ribcage where the liver sits. The probe sends gentle vibrations through your body and into the liver, then measures how quickly those vibrations travel. Faster vibrations mean stiffer, more scarred tissue. At the same time, the device captures information about fat content.
The main preparation requirement is straightforward: don’t eat or drink anything for three hours before your appointment. Food can temporarily change blood flow to the liver and affect the accuracy of the measurements. You don’t need to stop any medications unless your doctor specifically tells you to, and there’s no recovery time afterward.
Who Gets a FAST Score
The FAST score is typically ordered for people already known or suspected to have fatty liver disease. Your doctor might request one if routine blood work has shown elevated liver enzymes, if an imaging test has revealed fat in your liver, or if you have risk factors like obesity, type 2 diabetes, or metabolic syndrome that make liver disease progression more likely.
It’s also being used to track treatment response. A study examining patients on semaglutide (a medication originally developed for diabetes) found that changes in the FAST score over time reflected actual improvements in liver tissue, making it a useful tool for monitoring whether treatment is working without repeated biopsies. If your FAST score drops below 0.35 during treatment, that’s a strong signal that the inflammatory and scarring process in your liver is improving.